Lilly wins FDA nod for once-weekly insulin product, Onswik
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Strokes in young adults have nearly doubled over the last three decades - New study reveals
A new study published in Neurology reveals that stroke rates among young adults have nearly doubled over the past three decades, driven by rising risk factors.
Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development
FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical need FSHD Canada Foundation to provide up to US$5 million in non-dilutive…
CARF brings joy to children battling cancer
The Cancer Aid & Research Foundation (CARF) organised a special “Rose Day of Joy” programme for children battling cancer, giving them a break from treatment through a day of entertainment and…
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
— Meaningful and consistent efficacy trends across endpoints support continuing with Phase 3 development of 60 mg once daily remlifanserin in ADP, with demonstrated evidence of dose effect — Narrowly…
Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced encouraging findings from a…
Weight Loss Drugs Can Make You Blind
In the United States, more than 90 people have filed lawsuits against drug makers over claims that popular GLP-1 medicines … Read More The post Weight Loss Drugs Can Make You Blind appeared first on…